Betamimetics for suspected impaired fetal growth

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Say, Lale ^a   Gülmezoglu, A Metin ^a   Hofmeyr, G Justus ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Adrenergic beta agonists *therapeutic use ; Female; Fetal growth retardation *drug therapy ; Humans; Pregnancy; Randomized controlled trials as topic; Ritodrine therapeutic use ; Tocolytic agents *therapeutic use

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; PLACEBO; RITODRINE; ESTROGEN;

ANTHROPOMETRY; BIRTH WEIGHT; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; FETUS GROWTH; FETUS MOVEMENT; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANCY; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRASOUND; DRUG EFFICACY; HORMONAL THERAPY;

EID: 77950102876     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000036     Document Type: Review

References (15)

1. Cabero 1988 {published data only} Cabero L, Cerqueira MJ, del Solar J, Bellart J, Esteban-Altirriba J. Long-term hospitalization and beta-mimetic therapy in the treatment of intrauterine growth retardation of unknown etiology. Journal of Perinatal Medicine 1988;16:453-8.
2. Mori 1990 {published data only} Mori H, Aisaka K, Arai K, Okinaga S. Trial of ritodrine infusion for treatment of intrauterine growth retardation. Proceedings of 6th Congress of the Federation of the Asia-Oceania Perinatal Societies; 1990 Oct 22-26; Perth, Western Australia. 1990:46.
3. Chang 1977 {published data only} Chang A, Abell D, Beischer N, Wood C. Trial of intravenous therapy in women with low urinary oestriol excretion. American Journal of Obstetrics and Gynecology 1977;127:793-7.
4. Grant 1987 {unpublished data only} Grant AM. Oral salbutamol in the prevention of low birthweight in singleton pregnancies. Personal communication January 17 1987.
5. Renaud 1972 {published data only} * Brettes JP, Renaud R, Gandar R. A double-blind investigation into the effects of ritodrine on uterine blood flow during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology 1976;124:164-8.
6. Renaud R, Brettes P, Irrmann M, Boog G, Schumacher J, Gandar R. A double-blind cross-over trial to assess the effect of ritodrine on uterine blood flow in normal and pathologic pregnancies. A preliminary report. Proceedings of International Symposium on the Treatment of Fetal Risks; 1972 May; Baden, Austria. 1972:53-4.
7. Renaud 1976 {published data only} Renaud R, Bock A, Chambron J, Bonafous J, Rosenthal C, Raffi F. A simultaneous study of the placental, myometrial and cervical circulations (using Indium 113 and anemometric thermometry). A double blind study of the action of intravenous ritodrine in normal pregnancy. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1976;5:611-5.
8. Spellacy 1978 {published data only} Spellacy WN, Cruz AC, Buhi WC, Birk SA. The acute effects of ritodrine infusion on maternal metabolism: measurement of levels of glucose, insulin, glucagon, triglycerides, cholesterol, placental lactogen and chorionic gonadotropin. American Journal of Obstetrics and Gynecology 1978;131:637-42.
9. Varma 1987 {unpublished data only} Varma TR. A randomised double-blind comparison of ritodrine vs placebo in the treatment of intrauterine growth retardation. Personal communication September 29 1987.
10. Bernstein 2000 Bernstein IM, Horbar, JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very low birth weight infants with intrauterine growth restriction. The Vermont Oxford Network. American Journal of Obstetrics and Gynecology 2000;182:198.
11. Clarke 2000 Clarke M, Oxman AD, editors. Cochrane Reviewers' Handbook 4.1 [updated June 2000]. In: The Cochrane Library [database on CDROM]. The Cochrane Collaboration. Oxford: Update Software; 2000, Issue 2.
12. Harding 1992 Harding JE, Owens JA, Robinson JS. Should we try to supplement the growth retarded fetus? A cautionary tale. British Journal of Obstetrics and Gynaecology 1992;99:707-10.
13. Lin 1998 Lin C, Santolaya-Forgas J. Current concepts of fetal growth restriction: Part 1. Causes, classification, and pathophysiology. Obstetrics & Gynecology 1998;92(6):1044-55.
14. Resnik 2002 Resnik R. Intrauterine growth restriction. Obstetrics & Gynecology 2002;99(3):490-6.
15. RevMan 2000 The Cochrane Collaboration. Review Manager (RevMan). 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.